Investor Relations

Rigel's Mission

Rigel Pharmaceuticals is a biotechnology company dedicated to developing and commercializing novel, small molecule drugs that significantly improve the lives of patients with immune and hematological disorders, cancer and rare diseases.

Recent Event

40th Annual J.P. Morgan Healthcare Conference

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2020

mail icon

Sign Up For Email Alerts

Receive updates straight into your inbox

Sign up today

Investor Contact Information

Company

Rigel Pharmaceuticals, Inc.
1180 Veterans Blvd
South San Francisco, CA 94080

Investor Relations

Rigel Pharmaceuticals, Inc.
ir@rigel.com

Transfer Agent

EQ Shareowner Services
T: 800-401-1957